10x Genomics Holds Annual Stockholder Meeting
Ticker: TXG · Form: 8-K · Filed: Jun 5, 2025 · CIK: 1770787
| Field | Detail |
|---|---|
| Company | 10x Genomics, Inc. (TXG) |
| Form Type | 8-K |
| Filed Date | Jun 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, annual-meeting
Related Tickers: TXG
TL;DR
10x Genomics shareholders voted on directors and auditors at the annual meeting.
AI Summary
On June 3, 2025, 10x Genomics, Inc. filed an 8-K report to announce the results of its annual meeting of stockholders. The company's stockholders voted on several proposals, including the election of directors and the ratification of the appointment of its independent registered public accounting firm.
Why It Matters
This filing confirms the outcomes of shareholder votes, providing clarity on corporate governance and the company's financial oversight.
Risk Assessment
Risk Level: low — This is a routine filing reporting on the results of an annual stockholder meeting, with no new material financial or operational information.
Key Players & Entities
- 10x Genomics, Inc. (company) — Registrant
- June 3, 2025 (date) — Date of earliest event reported
FAQ
What was the primary purpose of the June 3, 2025 8-K filing by 10x Genomics, Inc.?
The primary purpose was to report the results of the company's annual meeting of stockholders.
What specific matters were voted on by the stockholders of 10x Genomics, Inc.?
The stockholders voted on proposals including the election of directors and the ratification of the appointment of the independent registered public accounting firm.
What is the exact name of the registrant filing the 8-K?
The exact name of the registrant is 10x Genomics, Inc.
In which jurisdiction was 10x Genomics, Inc. incorporated?
10x Genomics, Inc. was incorporated in Delaware.
What is the principal executive office address for 10x Genomics, Inc.?
The principal executive office address is 6230 Stoneridge Mall Road, Pleasanton, California 94588.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 5, 2025 regarding 10x Genomics, Inc. (TXG).